lenalidomide,daratumumab
janssen
philippe moreau presented an update on maia treatment with drd more that 18 mos associated with longer pfs and os don t stop dara too early but discontinuation of revlimid didn t compromise efficacy #ims2022 
Director of the Multiple Myeloma and Amyloidosis Service @columbiacancer - Associate Editor @JCO_ASCO - Tweets are my own